InspireMD Inc. [AMEX: NSPR] surged by $0.05 during the normal trading session on Monday and reaching a high of $0.53 during the day while it closed the day at $0.46. The company report on April 19, 2021 that InspireMD Provides Corporate Update for Shareholders.
InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR.WSB), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), provided an update of recent corporate developments.
Shareholders approved a 1:15 reverse stock split, reducing the number of outstanding shares from 118 million to 7.9 million shares, which will take effect following the close of trading on April 26, 2021.
InspireMD Inc. stock has also loss -20.96% of its value over the past 7 days. However, NSPR stock has declined by -23.96% in the 3 months of the year. Over the past six months meanwhile, it has gained 42.86% and gained 34.14% year-on date.
The market cap for NSPR stock reached $56.55 million, with 117.79 million shares outstanding and 107.70 million shares in the current float. Compared to the average trading volume of 16.26M shares, NSPR reached a trading volume of 17673014 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about InspireMD Inc. [NSPR]:
Rodman & Renshaw have made an estimate for InspireMD Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 07, 2016. The new note on the price target was released on March 13, 2015, representing the official price target for InspireMD Inc. stock. Previously, the target price had yet another raise to $6, while Oppenheimer analysts kept a Outperform rating on NSPR stock.
The Average True Range (ATR) for InspireMD Inc. is set at 0.07, with the Price to Sales ratio for NSPR stock in the period of the last 12 months amounting to 22.62. The Price to Book ratio for the last quarter was 1.43, with the Price to Cash per share for the same quarter was set at 0.10.
NSPR stock trade performance evaluation
InspireMD Inc. [NSPR] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -20.96. With this latest performance, NSPR shares dropped by -42.13% in over the last four-week period, additionally plugging by 42.86% over the last 6 months – not to mention a drop of -42.11% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NSPR stock in for the last two-week period is set at 32.16, with the RSI for the last a single of trading hit 27.70, and the three-weeks RSI is set at 36.76 for InspireMD Inc. [NSPR]. The present Moving Average for the last 50 days of trading for this stock 0.8081, while it was recorded at 0.4806 for the last single week of trading, and 0.5219 for the last 200 days.
InspireMD Inc. [NSPR]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and InspireMD Inc. [NSPR] shares currently have an operating margin of -406.60 and a Gross Margin at +3.34. InspireMD Inc.’s Net Margin is presently recorded at -424.31.
Return on Total Capital for NSPR is now -101.24, given the latest momentum, and Return on Invested Capital for the company is -109.84. Return on Equity for this stock declined to -120.19, with Return on Assets sitting at -76.25. When it comes to the capital structure of this company, InspireMD Inc. [NSPR] has a Total Debt to Total Equity ratio set at 11.50. Additionally, NSPR Total Debt to Total Capital is recorded at 10.32, with Total Debt to Total Assets ending up at 7.87. Long-Term Debt to Equity for the company is recorded at 8.21, with the Long-Term Debt to Total Capital now at 7.37.
Reflecting on the efficiency of the workforce at the company, InspireMD Inc. [NSPR] managed to generate an average of -$219,667 per employee. Receivables Turnover for the company is 2.59 with a Total Asset Turnover recorded at a value of 0.18.InspireMD Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.80 and a Current Ratio set at 4.10.
Earnings per share (EPS) analysis for InspireMD Inc. [NSPR] stock
With the latest financial reports released by the company, InspireMD Inc. posted -0.43/share EPS, while the average EPS was predicted by analysts to be reported at -0.63/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 31.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NSPR.
InspireMD Inc. [NSPR]: Insider Ownership positions
There are presently around $1 million, or 1.60% of NSPR stock, in the hands of institutional investors. The top three institutional holders of NSPR stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 1,243,100, which is approximately 753.496% of the company’s market cap and around 2.30% of the total institutional ownership; TWO SIGMA INVESTMENTS, LP, holding 202,113 shares of the stock with an approximate value of $83000.0 in NSPR stocks shares; and SABBY MANAGEMENT, LLC, currently with $72000.0 in NSPR stock with ownership of nearly -28.326% of the company’s market capitalization.
Positions in InspireMD Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 5 institutional holders increased their position in InspireMD Inc. [AMEX:NSPR] by around 1,390,894 shares. Additionally, 9 investors decreased positions by around 472,771 shares, while 3 investors held positions by with 10,595 shares. The mentioned changes placed institutional holdings at 1,853,070 shares, according to the latest SEC report filing. NSPR stock had 0 new institutional investments in for a total of 0 shares, while 7 institutional investors sold positions of 403,683 shares during the same period.